ISPOR Conference 2023
About
The conference was held explore strategies to address emerging healthcare challenges related to rare diseases and public health.
Date & Time:
June 13th - June 15th
June 13th : 8:00 am - 3:10 pm
June 14th : 8:00 am - 5:30 pm
June 15th : 8:00 am - 2:45 pm
Objectives
- Gaining insights into improving access to services and reimbursement pathways for rare disease treatments.
- Understanding opportunities and challenges in localizing and manufacturing pharmaceuticals.
- Examining the current status of infectious diseases in Saudi Arabia post-COVID-19 and evaluate ongoing public health responses.
- Assessing the role of private sector insurance policies and initiatives in enhancing healthcare coverage.
- Learning about the application of the Multi-Criteria Decision Analysis (MCDA) framework in rare disease management.
Agenda
Day 1:
Session I: Rare diseases: access to services and reimbursement of drugs
+
Dr. Mohammed Aljumah
The Prospects of Having a Mandatory Genetic Testing for All Commonly Encountered Rare Diseases
+
Dr. Amal Alhashim
Access to care: diagnosis, treatment and supportive care
+
Dr. Mohammed Almohaize
Approval and Registration of Orphan Medical Products by SFDA and Access to Treatment
+
Dr. Amani Alkofide
NICE experience with Managed Entry Agreements for orphan drugs
+
Dr. Grace Jennings
Session II: Localizing and Manufacturing Drugs (Open Panel Discussion)
+
Dr. Abdulmohsen Alsaleh
Local Content Status and Their Role in the Localization of Essential Medications
+
Eng. Abdulrahman Alsemari
Localization of Vaccines: Opportunities and Challenges
+
Dr. Mazen Hassanin
Localization of Generics: Opportunities and Challenges
+
Prof. Abdullah M. Al-Mohizea and Dr. Faisal Altlasi
Keynote Speech: Public-Private Partnership Initiatives
+
Prof. Mohammed Fakeeh & Dr. Yasser Almahmoud
Session III: Supply Chain and Public Health
+
Eng. Marie Alqahtani
Supply of Essential Medications: Shortages and Limited Access
+
Dr. Mohammed Alghmadi
Anti-Infective Medications Availability and Misuse
+
Dr. Abdullah Almoahizie
Incorporating PROs in Antimicrobial Studies
+
Dr. Sakra Balhareth
Saudi Vision 2030 Roadmap to Transform the Investment Landscape in the Medical Sector
+
TBD
Panel Discussion: HTA in Hospitals & Institution-Based Environment:
Implementation Aspects
+
Moderator: Dr. Abdullah Althemery
[Dr. Mohammed Alnahedh, Dr. Ahmed Aljedai, Dr. Hana Alabdulkarim, Dr. Abdullah Alrajhi]
Day 2:
Session IV: Infectious Diseases: KSA Status After The COVID-19 Outbreak
+
Dr. Thamir Almangour
COVID-19 Pandemic’s Impact on Influenza Virulence and Immunization Patterns in the KSA
+
Dr. Ayman Alsuhaibani
Access to Influenza and Other Infectious Diseases Vaccines During Haj And Umrah Season
+
Dr. Anas Khan
Global/Regional Experience in Dealing With Anti-Microbial Resistance
+
Dr. Heba Alrowaisan
Impact of Early Diagnosis/Screening on The Transmission of Infectious Diseases
+
Dr. Abdullah Alsultan
Session V: Private sector insurance Policies and initiatives
+
Dr. Reem Alsaqaaby
Health Holding Company: Overview
+
Dr. Faisal Alsaif
Public Awareness and Concerns About Healthcare Coverage in Private Sector
+
Dr. Othman Alkassabi
Availability and Access of Highly Innovative Medications: National Formulary
+
Dr. Nada Alageel
Session VI: Workshop (registration fees are required)
+
MCDA Framework for Rare Diseases
+
Dr. Abdulali Almutairi
CEA And BIM Example for Rare Diseases: Step by Step Implementation
+
Dr. Nimer Alkhatib
Pharmacovigilance database for orphan drugs: local experience & case studies
+
Dr. Fawaz Alharbi
Pharmacovigilance database for orphan drugs: local experience & case studies
+
Dr. Abdullah Alalwan
Day 3:
Session I: Poster sessions
+
Dr. Dema Alissa/ Dr. Yasser Almogbel
Session II: open panel discussion with The Saudi Society of medical genetics (SSMG)
+
Dr. Abdullah Althemery / Dr. Amal Alhashim
Session III: Job Fair (Pharmaceutical And Diagnostics Companies)
+
Download the Agenda
Media
Videos:
SPOR Day 2
SPOR Day 3
×
Images:
×
![Popup Image]()
